These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2005399

  • 1. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P, Chignard M.
    J Immunol; 1991 Apr 01; 146(7):2305-9. PubMed ID: 2005399
    [Abstract] [Full Text] [Related]

  • 2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P, Ferrer-Lopez P, Chignard M.
    Lab Invest; 1990 Apr 01; 62(4):409-16. PubMed ID: 2159081
    [Abstract] [Full Text] [Related]

  • 3. Synergism between interleukin-8 and tumor necrosis factor-alpha for neutrophil-mediated platelet activation.
    Si Tahar M, Renesto P, Balloy V, Chignard M.
    Eur Cytokine Netw; 1994 Apr 01; 5(5):455-60. PubMed ID: 7880976
    [Abstract] [Full Text] [Related]

  • 4. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P, Renesto P, Prevost MC, Gounon P, Chignard M.
    J Lab Clin Med; 1992 Mar 01; 119(3):231-9. PubMed ID: 1541873
    [Abstract] [Full Text] [Related]

  • 5. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P, Chignard M.
    J Lab Clin Med; 1994 Jun 01; 123(6):906-13. PubMed ID: 8201270
    [Abstract] [Full Text] [Related]

  • 6. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH, Cheng JT, Teng CM.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):158-67. PubMed ID: 16112105
    [Abstract] [Full Text] [Related]

  • 7. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T, Meyer-Hoffert U, Schröder JM, Wiedow O.
    Exp Dermatol; 2004 May 05; 13(5):316-25. PubMed ID: 15140022
    [Abstract] [Full Text] [Related]

  • 8. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G.
    Owen CA, Campbell MA, Boukedes SS, Campbell EJ.
    J Immunol; 1995 Dec 15; 155(12):5803-10. PubMed ID: 7499869
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
    Renesto P, Chignard M.
    Blood; 1993 Jul 01; 82(1):139-44. PubMed ID: 8324217
    [Abstract] [Full Text] [Related]

  • 10. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
    Selak MA.
    Thromb Haemost; 1992 Nov 10; 68(5):570-6. PubMed ID: 1333649
    [Abstract] [Full Text] [Related]

  • 11. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis.
    Maugeri N, Evangelista V, Celardo A, Dell'Elba G, Martelli N, Piccardoni P, de Gaetano G, Cerletti C.
    Thromb Haemost; 1994 Sep 10; 72(3):450-6. PubMed ID: 7531878
    [Abstract] [Full Text] [Related]

  • 12. The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation.
    Schleiffenbaum B, Fehr J.
    J Clin Invest; 1990 Jul 10; 86(1):184-95. PubMed ID: 2164042
    [Abstract] [Full Text] [Related]

  • 13. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
    Renesto P, Balloy V, Kamimura T, Masuda K, Imaizumi A, Chignard M.
    Br J Pharmacol; 1993 Apr 10; 108(4):1100-6. PubMed ID: 8097952
    [Abstract] [Full Text] [Related]

  • 14. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
    Duranton J, Adam C, Bieth JG.
    Biochemistry; 1998 Aug 11; 37(32):11239-45. PubMed ID: 9698370
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
    Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C.
    Blood; 1991 Jun 01; 77(11):2379-88. PubMed ID: 1645603
    [Abstract] [Full Text] [Related]

  • 16. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M.
    Am J Physiol; 1990 Jun 01; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.
    van Kessel KP, van Strijp JA, Verhoef J.
    J Immunol; 1991 Dec 01; 147(11):3862-8. PubMed ID: 1940372
    [Abstract] [Full Text] [Related]

  • 18. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation.
    Renesto P, Balloy V, Chignard M.
    Eur J Pharmacol; 1993 Aug 02; 248(2):151-5. PubMed ID: 8223961
    [Abstract] [Full Text] [Related]

  • 19. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
    Vercellotti GM, Moldow CF, Wickham NW, Jacob HS.
    J Lipid Mediat; 1990 Aug 02; 2 Suppl():S23-30. PubMed ID: 1966817
    [Abstract] [Full Text] [Related]

  • 20. Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent.
    Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ.
    Shock; 2006 Jul 02; 26(1):69-76. PubMed ID: 16783201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.